Avicin D Selectively Induces Apoptosis and Downregulates p-STAT-3, bcl-2, and Survivin in Cutaneous T-Cell Lymphoma Cells
Authors:
- 1 November 2008
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 128 (11) , 2728-2735
Abstract
No abstract availableKeywords
Funding Information
- University of Texas MD Anderson Cancer Center (CA 16672)
- National Institutes of Health (R21-CA 74117, K24-CA 86815)
This publication has 43 references indexed in Scilit:
- Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)Blood, 2006
- Phototherapy for cutaneous T-cell lymphomaDermatologic Therapy, 2003
- STAT proteins: From normal control of cellular events to tumorigenesisJournal of Cellular Physiology, 2003
- Efficacy of ultraviolet A1 phototherapy on the expression of bcl‐2 in atopic dermatitis and cutaneous T‐cell lymphoma in vivo: a comparison studyPhotodermatology, Photoimmunology & Photomedicine, 2002
- Bexarotene Is Effective and Safe for Treatment of Refractory Advanced-Stage Cutaneous T-Cell Lymphoma: Multinational Phase II-III Trial ResultsJournal of Clinical Oncology, 2001
- Constitutive STAT3-activation in Sezary syndrome: tyrphostin AG490 inhibits STAT3-activation, interleukin-2 receptor expression and growth of leukemic Sezary cellsLeukemia, 2001
- The relevance of the CD4+ CD26- subset in the identification of circulating Sézary cellsBritish Journal of Dermatology, 2001
- EMERGING NEW THERAPIES FOR CUTANEOUS T-CELL LYMPHOMADermatologic Clinics, 2000
- A novel anti-apoptosis gene, survivin, expressed in cancer and lymphomaNature Medicine, 1997
- Cleavage of poly(ADP-ribose) polymerase: a sensitive parameter to study cell deathBiochemistry and Cell Biology, 1997